Full results & analysis
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02000973Phase 4
Key facts
Phase 4, randomised, double-blind trial of lidocaine, bupivacaine and ropivacaine (4 arms), sponsored by First Hospital of China Medical University. Primary endpoint: Propofol Effect-site Concentration. Started Nov 2013; status: completed.
Normal saline
Thoracic epidural 0.9% normal saline + General anesthesia
Lidocaine
Thoracic epidural 1% lidocaine + General anesthesia
Bupivacaine
Thoracic epidural 0.25% bupivacaine + General anesthesia
Ropivacaine
Thoracic epidural 0.3% ropivacaine + General anesthesia
Patients undergoing thoracotomies with ASA classification I or II and BMI 18-25 kg/m2.
Propofol Effect-site Concentration
Mean Arterial Pressure
Heart Rate
Bispectral Index Score
Beyond the preview
Full results, competitive context and analysis are in the Gosset platform.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02000973.